Scientific World

Personalized Exercise Programs Urged for Chronic Lymphocytic Leukemia Patients

A new study led by the University of Surrey reveals that personalized exercise guidance is critically needed for people living with Chronic Lymphocytic Leukemia (CLL), the most common type of blood cancer. Published in eJHaem, the research highlights a significant gap in support, with 70% of surveyed patients reporting no exercise advice from healthcare providers, despite nearly 80% expressing interest in such programs.

The study surveyed 128 CLL patients across the UK and found that physical activity can markedly improve their quality of life. Active patients reported better daily functioning, reduced fatigue, less pain, and milder symptoms compared to their less active counterparts. However, structured prehabilitation and rehabilitation programs tailored for CLL patients are lacking in national healthcare systems, including the NHS.

Dr. David Bartlett, Senior Lecturer of Exercise Immunology at the University of Surrey, emphasized the study’s findings: “Patients are simply not receiving the guidance they need to engage safely and effectively in exercise, which can significantly improve their lives.”

The research also uncovered patient preferences, with most favoring virtual classes at home or in community clinics over hospital-based or group settings. Additionally, participants valued expert guidance from cancer care specialists, such as exercise physiologists and physiotherapists, over general fitness advice.

PhD student Ellie Miles added: “It’s not a one-size-fits-all solution. Treatment status and symptoms must be considered when developing CLL-specific exercise programs. Patients need expert, tailored advice to address their unique challenges.”

The study underscores the urgent need for healthcare systems to integrate personalized exercise programs for CLL patients, combining expert guidance with flexible, accessible formats. Future research could explore the long-term benefits of such interventions and their potential to complement standard treatments.

Add comment